Why the study?
Does intravenous dihydroergotamine improve hemodynamics in patients with systemic hypotension after combined general and epidural anesthesia?
Does intravenous dihydroergotamine improve hemodynamics in patients with systemic hypotension after combined general and epidural anesthesia?
Intravenous dihydroergotamine is unsuitable for treating hypotension after combined general and epidural anesthesia due to its adverse effect of significantly decreasing cardiac index.
May caution against DHE for post-anesthesia hypotension; leaves open net effects in larger cohorts.
Ten patients (63-80 years of age) scheduled for elective hip arthroplasty in whom systemic hypotension developed after combined general and epidural anesthesia were investigated. The necessary invasive monitoring was placed under local anesthesia. In a steady state, a baseline hemodynamic profile (HP) was obtained including systolic and mean arterial pressures, heart rate, cardiac index, and systemic and pulmonary vascular resistance; cardiac output was estimated by thermodilution. A second HP was recorded 30 minutes later, after epidural anesthesia with bupivacaine 0.5% reached a T7 level of analgesia. After the induction of general anesthesia, a new HP was obtained. When the mean arterial pressure was decreased by 30% despite intravenous fluids, 10 μg/kg of dihydroergotamine (DHE) was given intravenously, and 10 minutes later another HP was obtained. DHE restored normal systemic arterial pressure but the cardiac index decreased significantly ( p < 0.05). These findings make DHE unsuitable for the purpose described.
No takes yet. Share an insight, caveat, or question.
Lessire et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: